Stabilization
Preserves molecular structure and function over time, protecting compounds from degradation.
The company behind the
platform.
HyGyHya Global Industries is a licensing business, not a product brand. We build the technology our partners put inside their own pipelines.
The industry lacks the infrastructure to keep promising compounds intact on the way to market.
Provenance
Verifies material identity from the compound's own signature, for anti-counterfeiting and chain of custody.
Licensing Platform
Flexible integration across partner pipelines. Either engine deploys independently, or both run together.
A unified platform for performance and verification.
A licensing platform for molecular stabilization and lifecycle verification across plant-derived and complex bioactive compounds, deployable as either engine alone or as one integrated platform.
Protects active botanical compounds from oxidation, light, heat, and moisture to preserve potency and hold them within specification.
Verifies material identity from the compound's own chemical signature and binds it to a documented chain of custody. This is Engine Two.
Carrier systems designed for controlled release, reproducible dosing, and manufacturing-ready scalability.
Verifies compound integrity, quantifies actives, and produces release and validation documentation for partners.
The scientific, regulatory, and operational barriers in plant-derived compound development, and how the two engines address them.
How the platform works.
One engine holds the compound stable, the other proves its identity. Both license independently or together.
Stability: preserving molecular integrity from formulation to patient.
Stabilization protects active compounds from degradation, keeping pharmacokinetic behavior consistent across the lifecycle.
Provenance: product identity that persists beyond the label.
Engine Two establishes verifiable identity and traceability from the material itself, enabling anti-counterfeiting and chain-of-custody enforcement.
An integrated platform built for pharmaceutical licensing.
Both engines deploy independently or together, structured for B2B licensing, controlled supply, and partner diligence.
Leadership
Shawn Sizer
Co-Founder and Chief Executive Officer
View profileDr. James Woodford, Ph.D.
Co-Founder and Chief Science Officer
View profileDr. Robert F. Vogt, Ph.D.
Director of Regulatory Science and Platform Validation
View profileDon E. Wirtshafter
Strategic Advisor
View profilePatrick F. O'Reilly III
Intellectual Property Counsel
View profileRon Docie
Strategic Advisor
View profileFAQ
HyGyHya Global Industries is a licensing platform built around a unified Pharmaceutical Integrity Platform designed to address molecular instability and lifecycle discontinuity in plant-derived and complex bioactive compounds.
No. HyGyHya is a licensing platform positioned as infrastructure within pharmaceutical systems. We enable partners to integrate stabilization and product integrity technology into their existing pipelines.
We engage with pharmaceutical manufacturers, biotech companies, strategic partners, and qualified investors evaluating integration of our platform into development, manufacturing, or distribution systems.
HyGyHya is headquartered at 633 Chestnut Street, Suite 600, Chattanooga, TN 37450.